Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1984 Jan;43(1):122–126. doi: 10.1128/iai.43.1.122-126.1984

Induction of human gamma interferon by structurally defined polypeptide fragments of group A streptococcal M protein.

D A Weigent, E H Beachey, T Huff, J W Peterson, G J Stanton, S Baron
PMCID: PMC263397  PMID: 6418655

Abstract

The presence of interferon (IFN) has been demonstrated previously (i) in fluids obtained from the middle ears of children with Streptococcus pneumoniae infections, (ii) from the serum of mice injected intraperitoneally with either S. pneumoniae or Streptococcus pyogenes, and (iii) from human lymphoid cell cultures treated with a variety of bacteria. In this study, we showed that highly purified peptic extracts of three different serotypes of group A streptococcal M protein (pep M5, pep M6, and pep M24) stimulated human peripheral leukocytes to produce IFN. IFN production was apparent by 10 h and peaked 24 h after exposure. Dose-response experiments indicated that IFN could be detected in cultures treated with concentrations of M protein as low as 6 micrograms/ml, whereas maximum IFN production occurred at a concentration of 200 micrograms/ml. The IFN had antigenic and physicochemical characteristics of IFN-gamma. Preliminary leukocyte fractionation studies revealed that the IFN-producing cell was a nonadherent lymphocyte with receptors for sheep erythrocytes (T cell). Rabbit antisera specific for these structurally defined polypeptide fragments of streptococcal M protein (pep M5, pep M6, and pep M24) blocked IFN induction by each of the polypeptides. The data suggest that the different serotypes of streptococcal M protein may induce IFN by a common structural determinant shared by each of the polypeptide fragments tested.

Full text

PDF
122

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alkan M. L., Beachey E. H. Excretion of lipoteichoic acid by group A streptococci. Influence of penicillin on excretion and loss of ability to adhere to human oral mucosal cells. J Clin Invest. 1978 Mar;61(3):671–677. doi: 10.1172/JCI108979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Baron S., Howie V., Langford M., Macdonald E. M., Stanton G. J., Reitmeyer J., Weigent D. A. Induction of interferon by bacteria, protozoa, and viruses: defensive role. Tex Rep Biol Med. 1981;41:150–157. [PubMed] [Google Scholar]
  3. Beachey E. H., Alberti H., Stollerman G. H. Delayed hypersensitivity to purified streptococcal m protein in guinea pigs and in man. J Immunol. 1969 Jan;102(1):42–52. [PubMed] [Google Scholar]
  4. Beachey E. H., Dale J. B., Grebe S., Ahmed A., Simpson W. A., Ofek I. Lymphocytes binding and T cell mitogenic properties of group A streptococcal lipoteichoic acid. J Immunol. 1979 Jan;122(1):189–195. [PubMed] [Google Scholar]
  5. Beachey E. H., Stollerman G. H., Chiang E. Y., Chiang T. M., Seyer J. M., Kang A. H. Purification and properties of M protein extracted from group A streptococci with pepsin: covalent structure of the amino terminal region of type 24 M antigen. J Exp Med. 1977 Jun 1;145(6):1469–1483. doi: 10.1084/jem.145.6.1469. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Beachey E. H., Stollerman G. H., Johnson R. H., Ofek I., Bisno A. L. Human immune response to immunization with a structurally defined polypeptide fragment of streptococcal M protein. J Exp Med. 1979 Oct 1;150(4):862–877. doi: 10.1084/jem.150.4.862. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Beachey E. H., Stollerman G. H. Mediation of cytotoxic effects of streptococcal M protein by nontype-specific antibody in human sera. J Clin Invest. 1973 Oct;52(10):2563–2570. doi: 10.1172/JCI107448. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Blalock J. E., Langford M. P., Georgiades J., Stanton G. J. Nonsensitized lymphocytes produce leukocyte interferon when cultured with foreign cells. Cell Immunol. 1979 Mar 1;43(1):197–201. doi: 10.1016/0008-8749(79)90163-1. [DOI] [PubMed] [Google Scholar]
  9. Böyum A. Isolation of leucocytes from human blood. Further observations. Methylcellulose, dextran, and ficoll as erythrocyteaggregating agents. Scand J Clin Lab Invest Suppl. 1968;97:31–50. [PubMed] [Google Scholar]
  10. Cunningham C. M., Barsumian E. L., Watson D. W. Further purification of group A streptococcal pyrogenic exotoxin and characterization of the purified toxin. Infect Immun. 1976 Sep;14(3):767–775. doi: 10.1128/iai.14.3.767-775.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Dale J. B., Simpson W. A., Ofek I., Beachey E. H. Blastogenic responses of human lymphocytes to structurally defined polypeptide fragments of streptococcal M protein. J Immunol. 1981 Apr;126(4):1499–1505. [PubMed] [Google Scholar]
  12. Dianzani F., Monahan T. M., Georgiades J., Alperin J. B. Human immune interferon: induction in lymphoid cells by a calcium ionophore. Infect Immun. 1980 Aug;29(2):561–563. doi: 10.1128/iai.29.2.561-563.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Dianzani F., Monahan T. M., Scupham A., Zucca M. Enzymatic induction of interferon production by galactose oxidase treatment of human lymphoid cells. Infect Immun. 1979 Dec;26(3):879–882. doi: 10.1128/iai.26.3.879-882.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Donahoe R. M., Huang K. Y. Interferon preparations enhance phagocytosis in vivo. Infect Immun. 1976 Apr;13(4):1250–1257. doi: 10.1128/iai.13.4.1250-1257.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Fox E. N., Wittner M. K., Dorfman A. Antigenicity of the M proteins of group A hemolytic streptococci. 3. Antibody responses and cutaneous hypersensitivity in humans. J Exp Med. 1966 Dec 1;124(6):1135–1151. doi: 10.1084/jem.124.6.1135. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Gore M. M., Kedarnath N., Banerjea A. C., Ranbhor S. V., Ghosh S. N. Acid labile type alpha interferon induction by formalinized Staphylococcus aureus (Cowan I) in human mononuclear leukocytes. Indian J Med Res. 1983 Jun;77:770–776. [PubMed] [Google Scholar]
  17. Gray E. D. Purification and properties of an extracellular blastogen produced by group A streptococci. J Exp Med. 1979 Jun 1;149(6):1438–1449. doi: 10.1084/jem.149.6.1438. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Green J. A., Cooperband S. R., Kibrick S. Immune specific induction of interferon production in cultures of human blood lymphocytes. Science. 1969 Jun 20;164(3886):1415–1417. doi: 10.1126/science.164.3886.1415. [DOI] [PubMed] [Google Scholar]
  19. Greenberg L. J., Gray E. D., Yunis E. J. Association of HL-A 5 and immune responsiveness in vitro to streptococcal antigens. J Exp Med. 1975 May 1;141(5):935–943. doi: 10.1084/jem.141.5.935. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Hamburg S. I., Fleit H. B., Unkeless J. C., Rabinovitch M. Mononuclear phagocytes: responders to and producers of interferon. Ann N Y Acad Sci. 1980;350:72–90. doi: 10.1111/j.1749-6632.1980.tb20609.x. [DOI] [PubMed] [Google Scholar]
  21. Howie V., Pollard R. B., Kleyn K., Lawrence B., Peskuric T., Paucker K., Baron S. Presence of interferon during bacterial otitis media. J Infect Dis. 1982 Jun;145(6):811–814. doi: 10.1093/infdis/145.6.811. [DOI] [PubMed] [Google Scholar]
  22. Huang K. Y., Donahoe R. M., Gordon F. B., Dressler H. R. Enhancement of phagocytosis by interferon-containing preparations. Infect Immun. 1971 Nov;4(5):581–588. doi: 10.1128/iai.4.5.581-588.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Imanishi J., Yokota Y., Kishida T., Mukainaka T., Matsuo A. Phagocytosis-enhancing effect of human leukocyte interferon preparation of human peripheral monocytes in vitro. Acta Virol. 1975 Jan;19(1):52–58. [PubMed] [Google Scholar]
  24. Johnson H. M., Langford M. P., Lakhchaura B., Chan T. S., Stanton G. J. Neutralization of native human gamma interferon (HuIFN gamma) by antibodies to a synthetic peptide encoded by the 5' end of HuIFN gamma cDNA. J Immunol. 1982 Dec;129(6):2357–2359. [PubMed] [Google Scholar]
  25. Jondal M. SRBC rosette formation as a human T lymphocyte marker. Scand J Immunol. 1976 Jun;Suppl 5:69–76. doi: 10.1111/j.1365-3083.1976.tb03857.x. [DOI] [PubMed] [Google Scholar]
  26. Langford M. P., Stanton G. J., Johnson H. M. Biological effects of staphylococcal enterotoxin A on human peripheral lymphocytes. Infect Immun. 1978 Oct;22(1):62–68. doi: 10.1128/iai.22.1.62-68.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Langford M. P., Weigent D. A., Georgiades J. A., Johnson H. M., Stanton G. J. Antibody to staphylococcal enterotoxin A-induced human immune interferon (IFN gamma). J Immunol. 1981 Apr;126(4):1620–1623. [PubMed] [Google Scholar]
  28. Lindahl P., Leary P., Gresser I. Enhancement by interferon of the specific cytotoxicity of sensitized lymphocytes. Proc Natl Acad Sci U S A. 1972 Mar;69(3):721–725. doi: 10.1073/pnas.69.3.721. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Pachman L. M., Fox E. N. Cellular and antibody reactions to streptococcal M protein types 1, 3, 6 and 12. J Immunol. 1970 Oct;105(4):898–907. [PubMed] [Google Scholar]
  30. Pellegrino M. A., Ferrone S., Safford J. W., Jr, Hirata A. A., Terasaki P. I., Reisfeld R. A. Stimulation of lymphocyte transformation by streptococcal type M1 protein: relationship to HL-A antigens. J Immunol. 1972 Jul;109(1):97–102. [PubMed] [Google Scholar]
  31. Plate J. M., Amos B. Lymphocyte stimulation by a glycopeptide isolated from Streptococcus pyogenes C203S. I. Isolation and partial purification. Cell Immunol. 1970 Nov;1(5):476–487. doi: 10.1016/0008-8749(70)90036-5. [DOI] [PubMed] [Google Scholar]
  32. Saito M., Ebina T., Koi M., Yamaguchi T., Kawade Y., Ishida N. Induction of interferon-gamma in mouse spleen cells by OK-432, a preparation of Streptococcus pyogenes. Cell Immunol. 1982 Mar 15;68(1):187–192. doi: 10.1016/0008-8749(82)90102-2. [DOI] [PubMed] [Google Scholar]
  33. Santoli D., Trinchieri G., Lief F. S. Cell-mediated cytotoxicity against virus-infected target cells in humans. I. Characterization of the effector lymphocyte. J Immunol. 1978 Aug;121(2):526–531. [PubMed] [Google Scholar]
  34. Trinchieri G., Santoli D. Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Enhancement of human natural killer cell activity by interferon and antagonistic inhibition of susceptibility of target cells to lysis. J Exp Med. 1978 May 1;147(5):1314–1333. doi: 10.1084/jem.147.5.1314. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Weigent D. A., Langford M. P., Smith E. M., Blalock J. E., Stanton G. J. Human B lymphocytes produce leukocyte interferon after interaction with foreign cells. Infect Immun. 1981 May;32(2):508–512. doi: 10.1128/iai.32.2.508-512.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES